Form 8-K - Current report:
SEC Accession No. 0001193125-21-367920
Filing Date
2021-12-28
Accepted
2021-12-28 16:01:05
Documents
15
Period of Report
2021-12-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d470178d8k.htm   iXBRL 8-K 27382
2 EX-99.1 d470178dex991.htm EX-99.1 11152
7 GRAPHIC g470178dsp001a.jpg GRAPHIC 9876
  Complete submission text file 0001193125-21-367920.txt   215618

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA celu-20211227.xsd EX-101.SCH 3942
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celu-20211227_def.xml EX-101.DEF 13812
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE celu-20211227_lab.xml EX-101.LAB 22714
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celu-20211227_pre.xml EX-101.PRE 14781
9 EXTRACTED XBRL INSTANCE DOCUMENT d470178d8k_htm.xml XML 5346
Mailing Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019 2126163700
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 211524981
SIC: 2834 Pharmaceutical Preparations